Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06851546 · ClinicalTrials.gov registry record · NA
Efficacy of Selective Laser Trabeculoplasty Targeting Nasal Versus Inferior 180-degree
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT06851546: Completed NA study, sponsored by Mayo Clinic.
NCT06851546 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06851546, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The purpose of this study to optimize Selective Laser Trabeculoplasty (SLT) application when used in the management of open angle glaucoma (OAG)
Interventions
- PROCEDURE Nasal 180° Selective Laser Trabeculoplasty (SLT)
- PROCEDURE Inferior 180° Selective Laser Trabeculoplasty (SLT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2025-01-06 |
| Est. Completion | 2025-11-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06851546
The ClinicalTrials.gov registry entry for NCT06851546 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nasal 180° Selective Laser Trabeculoplasty (SLT) is the first listed.
NCT06851546 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06851546 about?
NCT06851546 is a clinical study titled "Efficacy of Selective Laser Trabeculoplasty Targeting Nasal Versus Inferior 180-degree". The purpose of this study to optimize Selective Laser Trabeculoplasty (SLT) application when used in the management of open angle glaucoma (OAG)
What is the current status of trial NCT06851546?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2025-01-06. Estimated completion is 2025-11-10.
What interventions are being tested in trial NCT06851546?
The interventions under investigation include: Nasal 180° Selective Laser Trabeculoplasty (SLT) (PROCEDURE), Inferior 180° Selective Laser Trabeculoplasty (SLT) (PROCEDURE).
Who is sponsoring clinical trial NCT06851546?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.